Related Experiment Videos
Laparoscopic Italian experience with the Lap-Band
L Angrisani1, M Alkilani, N Basso
1LapClub-Fondazione IDIS, Via Coroglio 156, 80124 Naples, Italy. lapclub.na@endosphere.it
Obesity Surgery
|July 4, 2001
Summary
Laparoscopic adjustable silicone gastric banding (LASGB) is a safe and effective bariatric surgery for morbid obesity. This study shows acceptable weight loss and low complication rates, supporting its wider use.
Area of Science:
- Bariatric Surgery
- Minimally Invasive Surgery
- Gastroenterology
Background:
- Increasing adoption of laparoscopic adjustable silicone gastric banding (LASGB) by surgeons with varied experience.
- Growing need for effective surgical treatments for morbid obesity.
Purpose of the Study:
- To evaluate the safety and efficacy of LASGB in a large cohort of Italian patients.
- To assess complication rates and weight loss outcomes following LASGB.
Main Methods:
- Prospective data collection from 1,265 patients undergoing LASGB in Italy since 1996.
- Data gathered from 23 surgeons using electronic patient data sheets.
- Follow-up at 6, 12, 18, 24, 36, and 48 months.
Main Results:
- No intra-operative mortality; 0.55% post-operative mortality unrelated to the procedure.
- Laparotomic conversion rate of 1.7%; 11.3% LASGB-related complications.
- Significant BMI reduction observed over 48 months, with mean BMI decreasing from 44.1 to 31.5.
Conclusions:
- LASGB is a safe and effective procedure for managing morbid obesity.
- The study supports the wider application of LASGB in clinical practice.
- Low complication and mortality rates indicate favorable outcomes.